Ligand Pharmaceuticals Inc. LGND
$252.27
▲ +0.38% 24H
About
Ligand Pharmaceuticals Inc. is a biopharmaceutical company that develops, acquires, and out-licenses proprietary technologies to assist pharmaceutical and biotechnology firms in discovering and developing novel medicines. It operates through research services and royalty-generating businesses, focusing on a diversified…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees47
TickerLGND
Statistics
Market Cap$5.05B
Revenue (TTM)$268.1M
Net Income$124.5M
Net Margin46.4%
EPS$6.13
P/E33.19
P/S18.59
P/B5.11
EV/EBITDA34.57
ROE17.1%
Dividend Yield—
Price$252.27
Data: Twelve Data · Revenue = mcap / P/S